Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, ...

From April 25 to 30, 2025, the American Association for Cancer Research (AACR) Annual Meeting will take place in Chicago. CStone will showcase its latest preclinical studies on five internally ...

Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at ...

PARP7 is a mono-ADP-ribosyl transferase (mono-ART) which has recently gained attention due to its emerging role as a negative ...

Phase III DIPPER trial shows that adjuvant camrelizumab administered after induction-concurrent chemoradiotherapy ...

经观健康 经济观察网讯 ...

“It’s clearly what everybody’s been looking for.” In the wake of Summit’s results, drugs like ivonescimab, which block cell signaling via proteins called PD-1 and VEGF, have become the “new shiny ...

1Division of Pediatrics, Neuro-Oncology Section, MD Anderson Cancer Center, Houston, Texas. 2Georgia Cancer Center, Augusta University, Augusta, Georgia. *Corresponding Author: Aaron E. Fan, Division ...

Department of Physiology, State Key Laboratory of Common Mechanism Research for Major Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Basic Medical ...

School of Life Science, Tianjin University, 92 Weijin Road, Tianjin 300072, China Frontiers Science Center for Synthetic Biology (Ministry of Education), Tianjin Key Laboratory of Function and ...